Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
WDB coco CoTSE:7079 +0.23%72 Debt-to-EBITDA is 0.06 as of Mar. 2026, which is 200% above its 10-year median of 0.02. GuruFocus rates TSE:7079 with a GF Score™ of 72/100 and a GF Value™ of 円3,580.71 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 480 Healthcare Providers & Services companies, WDB coco Co ranks better than 96.25% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for WDB coco Co's Debt-to-EBITDA or its related term are showing as below:
TSE:7079'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.01 Med: 0.02 Max: 0.08
Current: 0.05
During the past 9 years, the highest Debt-to-EBITDA Ratio of WDB coco Co was 0.08. The lowest was 0.01. And the median was 0.02.
TSE:7079's Debt-to-EBITDA is ranked better than 96.25% of 480
companies
in the Healthcare Providers & Services industry
Industry Median: 2.185
vs TSE:7079: 0.05
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
WDB coco Co Debt-to-EBITDA Related Terms
WDB coco Co Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for WDB coco Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7079 vs VEEV, BTSG, HQY: Debt-to-EBITDA Comparison
For the Health Information Services subindustry, WDB coco Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WDB coco Co Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, WDB coco Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where WDB coco Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
WDB coco Co (TSE:7079) has a Debt-to-EBITDA of 0.06 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on WDB coco Co. This is 200% above median its historical median of 0.02. Over the past decade, WDB coco Co's Debt-to-EBITDA has ranged from 0.01 to 0.08. According to the industry distribution chart, WDB coco Co ranks #18 out of 480 companies in the Healthcare Providers & Services industry, placing it in the top 3.7%.
Is WDB coco Co's Debt-to-EBITDA too high?
WDB coco Co's current Debt-to-EBITDA of 0.06 is 200% above median its 10-year median of 0.02. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.08. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.19. WDB coco Co's value of 0.06 is 97.3% below this industry median. Based on the distribution chart, WDB coco Co ranks #18 out of 480 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, WDB coco Co has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WDB coco Co's Debt-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, WDB coco Co ranks #18 out of 480 companies for Debt-to-EBITDA. This places WDB coco Co in the top 4% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.19. WDB coco Co's value of 0.06 is 97.3% below this benchmark. Historically, WDB coco Co's own Debt-to-EBITDA has ranged from 0.01 to 0.08 over the past decade. While the company's 10-year median is 0.02 vs. the industry median of 2.19, WDB coco Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 480 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WDB coco Co's current Debt-to-EBITDA of 0.06 is 97.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on WDB coco Co. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WDB coco Co's current Debt-to-EBITDA is 0.06, which is 200% above median its own 10-year median of 0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WDB coco Co stock overvalued right now?
Based on GuruFocus' analysis, WDB coco Co (TSE:7079) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,580.71, compared to a current price of 円2,582.00 — trading 27.9% below its estimated fair value. The current Debt-to-EBITDA is 0.06, which is 200% above median its 10-year median of 0.02 and 97.3% below the Healthcare Providers & Services industry median of 2.19. WDB coco Co's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For WDB coco Co (TSE:7079), the current Debt-to-EBITDA is 0.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WDB coco Co (TSE:7079) Overvalued in 2026?
Based on GuruFocus' analysis, WDB coco Co stock appears to be undervalued.
The current stock price of 円2,582.00 is trading 27.9% below its estimated GF Value™ of 円3,580.71.
GuruFocus considers WDB coco Co to be Modestly Undervalued.
Key valuation signals for TSE:7079:
Debt-to-EBITDA: 0.06 (200% above median its 10-year median of 0.02)
GF Value™: 円3,580.71 vs. price of 円2,582.00 (27.9% below fair value)
Industry Position: 97.3% below the Healthcare Providers & Services median (#18 of 480)
No single metric tells the full story. See the TSE:7079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC-related work, PMS facility contract support related work, clinical research support/monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments, such as monitoring, safety information, data management, and statistical analysis. It provides support for the development of generic drugs, such as bioequivalence studies and biosimilars, clinical research, and physician-led clinical trials.
72GF Score
Get the complete analysis for TSE:7079
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7079 has been successfully added to your 
